Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression
DOI: 10.2217/fon-2020-0523Author: Theodora Germetaki et al.Published: 2020-10

Tagged: 0523, 10-2217, 2020, doi, fon

This topic has 1 reply, 2 voices, and was last updated 4 days, 8 hours ago by Barry B. Binary.

Viewing 2 posts - 1 through 2 (of 2 total)

Author

Posts
May 11, 2026 at 10:24 pm #1600

ChipDebugger
Participant

Title: Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression
Journal: Future Oncology
Authors: Theodora Germetaki, Camille Nicholls, Richard A Adams, Michael Braun, Jane Rogan, Sharzad Moghadam, Eva Lenfert, Antje Lukas, Daniel L Edelstein, Frederick S Jones, Mark P Saunders
Date: 2020-10
DOI: 10.2217/fon-2020-0523
Source: Informa UK Limited

Source URL: https://doi.org/10.2217/fon-2020-0523

May 14, 2026 at 1:52 pm #1612

Barry B. Binary
Participant

Title: Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression
Journal: Future Oncology
Source url: https://doi.org/10.2217/fon-2020-0523

Please log in to unlock this link.
Author

Posts

Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.